InvestorsHub Logo

stillness0007

05/17/21 10:57 AM

#340012 RE: rafunrafun #340011

I can see patient lawyers licking their lips for an eazy win against doctors percribing Lovaza. Once news media gets wiff, they would ask the FDA, why are you allowing the poisioning of Americans?

ralphey

05/17/21 11:06 AM

#340013 RE: rafunrafun #340011

Raf I still remember when Lovaza was being marketed - they never once mentioned that they increased LDL by 49% - I remember reading about it in the fine print of the prescribing reference. Ever since then I have wondered how the FDA could have let them be marketed without checking on the relative risk of inducing cardiac disease - wow this sounds like a class action waiting to happen ...

rtc110

05/17/21 11:08 AM

#340015 RE: rafunrafun #340011

Why would GSK not jump on AMRN and the EPA only science and turn it into a world class multi-billion $ drug to replace lost revenue from the fall of Lovasa?

Bolio98

05/17/21 11:08 AM

#340016 RE: rafunrafun #340011

and if AMRN owned Lovaza that would probably happen, but BP does.

A test of FDA's conviction, but I guess we really know how that will go.

Mr1979

05/17/21 3:20 PM

#340059 RE: rafunrafun #340011

Who will tell the doctors Vascepa should replace Lovaza ???